2024 annual financial data
Alaunos Therapeutics 2024 Operating margin
Direct answer
Operating margin was -48,120%.
Operating income was -4,812,000 USD and net income was -4,679,000 USD.
Operating cash flow was -4,971,000 USD.
Get free Alaunos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,000 USD
- Operating income
- -4,812,000 USD
- Net income
- -4,679,000 USD
- Operating cash flow
- -4,971,000 USD